J.W. COLE ADVISORS, INC. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 673 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
J.W. COLE ADVISORS, INC. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2024$1,857,696
+92.8%
54,751
+79.7%
0.09%
+77.6%
Q1 2024$963,630
+42.5%
30,474
+39.8%
0.05%
+22.5%
Q4 2023$676,138
+14.2%
21,804
-0.9%
0.04%
-9.1%
Q3 2023$592,121
-53.7%
22,004
-48.2%
0.04%
-51.6%
Q2 2023$1,279,475
-7.3%
42,493
-0.4%
0.09%
-7.1%
Q1 2023$1,380,095
+45.2%
42,661
+28.6%
0.10%
+34.2%
Q4 2022$950,789
+100.6%
33,174
+68.9%
0.07%
+82.5%
Q3 2022$474,000
-8.8%
19,638
+3.3%
0.04%
-2.4%
Q2 2022$520,000
-40.4%
19,005
-16.5%
0.04%
-30.5%
Q1 2022$873,000
+35.6%
22,757
+13.2%
0.06%
+40.5%
Q4 2021$644,000
+5.9%
20,111
+12.5%
0.04%
-12.5%
Q2 2021$608,000
+37.2%
17,881
+31.3%
0.05%
+11.6%
Q1 2021$443,000
-16.4%
13,618
-7.5%
0.04%
-21.8%
Q4 2020$530,000
+31.2%
14,726
+42.6%
0.06%
+77.4%
Q3 2020$404,000
-73.5%
10,327
-75.2%
0.03%
-86.5%
Q2 2020$1,527,000
+61.9%
41,623
+29.2%
0.23%
+93.3%
Q4 2019$943,00032,2060.12%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders